You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 18, 2025

Drugs Containing Excipient (Inactive Ingredient) FERRIC OXIDE RED


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing FERRIC OXIDE RED excipient, and estimated key patent expiration / generic entry dates

Ferric Oxide Red: Market Dynamics and Financial Trajectory in the Pharmaceutical Sector

Introduction to Ferric Oxide Red

Ferric oxide red, also known as iron(III) oxide (Fe2O3), is a widely used coloring agent in the pharmaceutical industry. It is utilized in the production of tablets and capsules due to its inert and non-reactive properties, making it an ideal excipient[4].

Market Size and Growth

The global market for pharmaceutical excipients, which includes ferric oxide red, is experiencing significant growth. As of 2023, the global pharmaceutical excipients market was valued at $9.2 billion and is expected to grow to $12.4 billion by 2029, at a CAGR of 5.1% from 2024 to 2029[3].

Specific Market for Ferric Oxide

While the overall pharmaceutical excipients market provides a broad context, the specific market for ferric oxide red is influenced by its various applications. Ferric oxide red is part of the larger iron oxide market, which includes other types of iron oxides used in different industries.

  • The iron oxide market, including pigments and other forms, was valued at USD 2.15 Billion in 2024 and is projected to reach USD 3.05 Billion by 2031, growing at a CAGR of 4.50% from 2024 to 2031[5].

Key Drivers

Increasing Demand in Pharmaceuticals

The rise in chronic diseases such as diabetes, hypertension, cancer, and HIV drives the demand for innovative and effective drug formulations. Ferric oxide red, as a coloring agent, plays a crucial role in enhancing the appearance and acceptability of pharmaceutical products, contributing to the overall growth of the pharmaceutical excipients market[3].

Regulatory Compliance

The FDA's regulatory review for color additives ensures that ferric oxide red meets stringent safety and quality standards. This compliance is a driver for its continued use and acceptance in the pharmaceutical industry[4].

Cosmetic and Personal Care Industries

Apart from pharmaceuticals, ferric oxide red is also used in the cosmetics and personal care industries, which adds to its overall market demand. The growth in these sectors further bolsters the financial trajectory of ferric oxide red[4].

Challenges and Risks

Raw Material Volatility

The production costs of ferric oxide red are directly influenced by fluctuations in iron ore prices. Disruptions in mining operations, trade disputes, or changes in global demand can lead to price volatility, affecting the cost structure and profitability of manufacturers. This volatility can impact the overall financial stability of companies producing ferric oxide red[5].

Supply Chain Disruptions

The COVID-19 pandemic highlighted the vulnerability of supply chains, particularly in industries reliant on global sourcing. Reduced demand, lockdowns, and labor shortages can significantly impact the production and distribution of ferric oxide red, leading to market instability[2].

Regional Analysis

Global Infrastructure Spending

Global infrastructure spending, which includes construction and building projects, is a significant driver for the iron oxide market. Regions with high infrastructure development plans, such as Asia-Pacific, are expected to drive the demand for iron oxides, including ferric oxide red. For instance, the Asia-Pacific region is forecasted to see substantial growth due to its robust infrastructure plans[2].

Regional Market Breakdown

  • North America and Europe: These regions have established pharmaceutical and cosmetic industries, which contribute to the steady demand for ferric oxide red.
  • Asia-Pacific: This region is expected to grow at a faster pace due to increasing infrastructure and industrial activities, as well as growing demand in the pharmaceutical and cosmetic sectors[1].

Competitive Landscape

The market for ferric oxide red is competitive, with several key players involved in its production and distribution. Companies such as BASF SE, Ashland Global, and Croda International Plc are significant players in the pharmaceutical excipients market, including ferric oxide red. These companies leverage their expertise and resources to drive innovation and sustainability in excipient development[3].

Strategic Initiatives

Innovation and Sustainability

Leading companies are focusing on innovative and sustainable practices in the production of ferric oxide red. This includes the development of synthetic iron oxides that meet high-quality standards and are environmentally friendly.

Operational Integration

Operational integration and strategic partnerships are crucial for maintaining a competitive edge. Companies are investing in advanced manufacturing technologies and supply chain optimization to mitigate risks associated with raw material volatility and supply chain disruptions[1].

Emerging Trends

Increasing Use in Wastewater Treatment

Apart from its traditional uses, ferric oxide red is also being explored for its potential in wastewater treatment. The use of iron oxide nanoparticles in environmental applications is an emerging trend that could further expand the market for ferric oxide red[1].

Regulatory Changes

Changes in regulatory standards and increasing scrutiny over the use of color additives in pharmaceuticals and cosmetics could impact the market dynamics. Companies must stay abreast of these changes to ensure compliance and maintain market share[4].

Key Takeaways

  • Market Growth: The pharmaceutical excipients market, including ferric oxide red, is expected to grow significantly, driven by increasing demand in pharmaceuticals and cosmetics.
  • Raw Material Volatility: Fluctuations in iron ore prices pose a significant challenge to the production costs and profitability of ferric oxide red manufacturers.
  • Regional Growth: Asia-Pacific is expected to be a key growth region due to its robust infrastructure plans and growing pharmaceutical and cosmetic industries.
  • Competitive Landscape: The market is competitive, with key players focusing on innovation, sustainability, and operational integration.

FAQs

Q: What is ferric oxide red used for in the pharmaceutical industry?

A: Ferric oxide red is used as a coloring agent for tablets and capsules in the pharmaceutical industry.

Q: How does the global infrastructure spending impact the market for ferric oxide red?

A: Global infrastructure spending drives the demand for iron oxides, including ferric oxide red, particularly in regions with high construction and building activities.

Q: What are the key challenges facing the production of ferric oxide red?

A: The key challenges include raw material price volatility, supply chain disruptions, and regulatory changes.

Q: Which regions are expected to see significant growth in the demand for ferric oxide red?

A: The Asia-Pacific region is expected to see substantial growth due to its robust infrastructure plans and growing pharmaceutical and cosmetic industries.

Q: How are leading companies in the market addressing the challenges and opportunities?

A: Leading companies are focusing on innovation, sustainability, operational integration, and strategic partnerships to maintain a competitive edge and mitigate risks.

Sources:

  1. Ferric Oxide Market Report: Trends, Forecast and Competitive Analysis - ResearchAndMarkets
  2. Iron Oxide Market Share, Size and Industry Growth Analysis 2022 - IndustryARC
  3. Understanding the Future of Pharmaceutical Excipients - BCC Research
  4. Ferric Oxide Red: What is it and where is it used? - Drugs.com
  5. Iron Oxide Pigments Market Size, Share, Trends & Forecast - Verified Market Research

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.